Indobufen, (S)-

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-1994
01219901994

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1994
Highly Cited
1994
The aim of our study was to characterize a model of human prostaglandin endoperoxide synthase-2 (PGHS-2) expression allowing the… (More)
Is this relevant?
1992
1992
The plasma pharmacokinetics and urinary elimination of the enantiomers of indobufen (2-[p-(1-oxo-2-isoindolinyl)-phenyl]butyric… (More)
Is this relevant?
1990
1990
Racemic indobufen inhibits human platelet aggregation by reducing thromboxane (TX) A2 biosynthesis. In order to ascertain which… (More)
Is this relevant?
1990
1990
The plasma pharmacokinetics and urinary elimination of the enantiomers of indobufen, a novel platelet aggregation inhibitor, have… (More)
Is this relevant?